Indivior Share Discussion Threads

[the grumpy old men] 10/4/2019 08:52

Alexander Bueso
Sharecast News
10 Apr, 2019 08:32
Indivior crashes after indictment by US federal grand jury, drags Reckitt lower
gsk glaxo pharma drug laboratory worker
Indivior
48.70
08:34:42 10/04/19


A US jury has indicted Indivior for fraudulently flogging its Suboxone Film drug as a safer alternative to rival treatments for opiod addiction.


News of the federal grand jury's decision to formally bring charges against the specialty pharmaceuticals outfit saw the company's shares crash by 44% and prompted a quick response from the company.

The allegations against it referred to actions that took part "almost exclusively" prior to Indivior being spun-off from Reckitt Benckiser, at the end of 2014, the company said in a statement.

Indivior defended itself further, saying the allegations were unsupported by both the facts and the law, including those from the main US regulator, the Food and Drug Administration and the Centers for Disease Control in Atlanta.

Nonetheless, management conceded that a negative verdict might have a "material adverse" effect on its financial position and outlook and lamented the DoJ's decision not to accept their offer for a settlement.

[lw425] 10/4/2019 08:51

whats the target price on the downside?

[dealy] 10/4/2019 08:36

did analysts know about this risk?

[bookbroker] 10/4/2019 08:34

This company was part of RB. at the time, so are they complicit?

[newtothisgame3] 10/4/2019 08:31

#INDV Indivior share price nearly halves on drug scheme allegations

[buywell3] 10/4/2019 08:28

You were warned :


buywell3 - 23 Nov 2018 - 01:21:03 - 182 of 349 INDIVIOR THE PILL WITH NO CHEERS OR BEERS - INDV

What a bunch of tw@ts that took this to 500p in 2018

And that was after the chances of USA legal actions were known

Amazing the amount of investors funds that have been squandered

Do some still buying thinking that a small company based outside the USA in the UK is going to win a ruling in their favor in American courts ?

Averaging down is not a wise thing when the facts are very much V the reality of the situation

USA BIG PHARMA is running the show



Buyers of this share are taking on the USA BIG PHARMA lobby in the states ... and the FDA and other regulatory USA bodies

Who is going to win ?

[rafieh] 10/4/2019 08:21

And may be 15P a year from now.

[the grumpy old men] 10/4/2019 08:21

Statement of Indivior on Grand Jury Indictment

Company Disputes Allegations and Will Contest Them

Slough, UK, and Richmond, VA, April 10, 2019 - Indivior PLC (LON: INDV) ("Indivior" or the "Company") announced that on April 9, 2019 a grand jury in the Western District of Virginia issued an indictment in connection with the federal criminal investigation initiated by the Department of Justice in December 2013.

The indictment includes twenty-eight felony counts - one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and twenty-two counts of wire fraud. The allegations are based on actions that occurred almost exclusively prior to Indivior becoming an independent company in its demerger from Reckitt Benckiser Group plc at the end of 2014. The Company believes the allegations are unsupported by the facts and the law. Key allegations have been contradicted by the U.S. government's scientific agencies, the Food and Drug Administration and the Centers for Disease Control.

While the Company cannot predict the timing with certainty, similar cases can take twelve months or more to be heard. While the Company believes that it will successfully defend itself against the government's allegations, an adverse verdict may have a material adverse effect on the Company and its financial position and outlook.

Indivior has cooperated extensively with the Justice Department's investigation for several years. In the interest of resolving this matter and providing certainty to its shareholders, the Company made numerous attempts to reach a settlement that went far beyond what it believes the facts of the case support. The Company believes it is unfortunate the Justice Department decided to choose an alternative path, but will fight these allegations on the facts and the law in court.

In terms of business going forward, the Company will continue to follow its mission of helping patients struggling with opioid addiction. It does not anticipate any immediate change in its relationship with government providers due to today's actions by the Department of Justice.

A statement from the company responding to the Justice Department's action is appended below. Further information, including an open letter from its Chairman, may be found on the Company's website at www.indivior.com/commitment.

[dealy] 10/4/2019 08:14

these were 500p a year ago

[rafieh] 10/4/2019 08:10

May bounce a bit later today, but long term outlook is as gloomy as it gets.

[newtothisgame3] 10/4/2019 06:25

#INDV #Indivior is charged in US over opioid treatment drug

[dealy] 10/4/2019 06:11

how bad do you think this is?

[newtothisgame3] 10/4/2019 05:58

#INDV The Times: London-listed #Indivior has been accused of engaging in an alleged scheme to increase prescriptions of Suboxone Film, its opioid treatment, by deceiving healthcare providers about the drug’s safety.

[newtothisgame3] 09/4/2019 02:56

#Indivior (#INDV) The latest guidance from the company points to potential sales of Sublocade Suboxone's active ingredient, in the bloodstream throughout the month – to be between $50m and $70m this year. We remain sellers.

[grupo guitarlumber] 08/4/2019 13:02

BEARISH BUT NICE MOVE UP

[dealy] 08/4/2019 12:49

thanks Grupo. Market has priced in zero probability of the company being able to limit the impact of the generics

[grupo guitarlumber] 08/4/2019 11:59

an interesting history

[grupo guitarlumber] 08/4/2019 11:37

IMO I feel that there are substle differences and if people believe this to be so they will go for the original or
wish to buy a well known brand

i guess its about confidence not just price

[dealy] 08/4/2019 11:29

are the generics really identical to the original formulation?

[la forge] 06/4/2019 10:31

Indivior to Announce First Quarter 2019 Results on May 2nd and Host Conference Call

Slough, UK, and Richmond, VA, 4 April 2019 - Indivior PLC (LON: INDV) today announced that it will release its first quarter 2019 results on May 2(nd) at 12:00 BST (7:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the Company's website at www.indivior.com.

Key members of Indivior's leadership team led by Shaun Thaxter, Chief Executive Officer, will host a conference call to discuss the results and address questions from qualified analysts and investors at 13:00 BST (8:00 a.m. U.S. Eastern) on May 2(nd) .

Access the Live Webcast for the Results Call on May 2nd

The webcast event will be available on the "Investors" section of the Company's website at www.indivior.com. The webcast link is hxxps://edge.media-server.com/m6/p/o2rwcu9e. Participants also may access the results presentation telephonically: US participants 1-323-794-2149; international participants 44(0)330-336-9411. Please reference confirmation code 1140953. A replay of the presentation will be available at www.indivior.com.